product summary
Loading...
company name :
BioLegend
other brands :
Babco, Signet, Sternberger Monoclonals, Senetek, Covance
product type :
antibody
product name :
Purified anti-human CD262 (DR5, TRAIL-R2)
catalog :
307402
quantity :
100 μg
price :
206 USD
clonality :
monoclonal
host :
mouse
conjugate :
nonconjugated
clone name :
DJR2-4 (7-8)
reactivity :
human
application :
flow cytometry, other
more info or order :
citations: 5
Published Application/Species/Sample/Dilution | Reference |
---|---|
| |
| |
| |
Lundqvist A, Abrams S, Schrump D, Alvarez G, Suffredini D, Berg M, et al. Bortezomib and depsipeptide sensitize tumors to tumor necrosis factor-related apoptosis-inducing ligand: a novel method to potentiate natural killer cell tumor cytotoxicity. Cancer Res. 2006;66:7317-25 pubmed
|
product information
Antigen :
CD262
Apps. Abbrev. :
Flow Cytometry
Cat # :
307402
Clone :
DJR2-4 (7-8)
Item :
Purified anti-human CD262 (DR5, TRAIL-R2)
Isotype :
Mouse IgG1, κ
Other Names :
TRAIL-R2, KILLER, TRICK2, TNFRSF10B, Ly98, CD262
Size :
100 μg
Price (USD) :
206 USD
Reactivity :
Human
Clonality :
Monoclonal
Host :
Mouse
Conjugate/Tag/Label :
PURE
Immunogen :
Extracellular domain of DR5-human IgG1 Fc fusion protein
Application Notes :
Additional reported applications (for the relevant formats) include: The DJR2-4 antibody is useful for immunofluorescent staining and flow cytometric analysis of DR5/TRAIL-R2 receptor expression. For most successful immunofluorescent staining results, it may be important to maximize signal over background by using a relatively bright fluorochrome-antibody conjugate (Cat. No. 307406) or by using a high sensitivity, three-layer staining technique (e.g., including a biotinylated antibody (Cat. No. 307404) or biotinylated anti-mouse IgG second step (Cat. No. 405303), followed by SAv-PE (Cat. No. 405204)).
more info or order :
company information

BioLegend
8999 BioLegend Way
San Diego, CA 92121
San Diego, CA 92121
customerserv@biolegend.com
https://www.biolegend.comheadquarters: USA
browse more products
questions and comments